We are live on
!
Find out more
Temasek Holdings Portfolio holdings
AUM
$37.3B
Turnover
40.09%
1-Year Est. Return
12.6%
This Fund
S&P 500
This Quarter
Est. Return
-0.17%
1 Year Est. Return
+12.6%
3 Year Est. Return
+93.72%
5 Year Est. Return
+64.47%
10 Year Est. Return
+501.94%
AUM
$16.3B
AUM Growth
-$906M
(-5.3%)
Cap. Flow
-$922M
Cap. Flow
% of AUM
-5.67%
Top 10 Holdings %
Top 10 Hldgs %
71.33%
Holding
67
New
6
Increased
8
Reduced
6
Closed
4
Avg Time Held
1.4
years
Top 10 Avg Time Held
1.6
years
Top 20 Avg Time Held
2.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lumen Technologies, Inc. Common Stock
LUMN
|
+$1.58B |
| 2 |
DuPont de Nemours
DD
|
+$400M |
| 3 |
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
|
+$178M |
| 4 |
Boeing
BA
|
+$142M |
| 5 |
BeOne Medicines Ltd
ONC
|
+$82.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LVLT
Level 3 Communications Inc
LVLT
|
+$3.47B |
| 2 |
ATH
Athene Holding Ltd. Class A Common Shares
ATH
|
+$46.4M |
| 3 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$9.88M |
| 4 |
JPMorgan Chase
JPM
|
+$8.92M |
| 5 |
Bank of America
BAC
|
+$7.33M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 43.88% |
| 2 | Healthcare | 15.43% |
| 3 | Communication Services | 14.5% |
| 4 | Financials | 8.64% |
| 5 | Materials | 8.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Mastercard
MA
$540B
| $140M | 0.86% |
923,068
| – | – |
2016 Q4
4 quarters
|
|
|
27
BeOne Medicines Ltd
ONC
$42.3B
| $125M | 0.77% |
1,280,000
+900,000
| +237% | +$82.4M |
2016 Q1
7 quarters
|
|
|
WP
28
DELISTED
Worldpay, Inc.
WP
| $97.6M | 0.6% |
1,327,057
+345,000
| +35% | +$24.7M |
2017 Q3
1 quarter
|
|
29
Broadcom
AVGO
$1.64T
| $96.6M | 0.59% |
3,760,500
| – | – |
2017 Q2
2 quarters
|
|
30
VNET Group
VNET
$1.26B
| $86M | 0.53% |
10,778,004
| – | – |
2013 Q4
16 quarters
|
|
|
CBPO
31
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $78M | 0.48% |
990,000
+953,005
| +2,576% | +$79.2M |
2017 Q3
1 quarter
|
|
32
Regeneron Pharmaceuticals
REGN
$82B
| $71.7M | 0.44% |
190,621
| – | – |
2015 Q4
8 quarters
|
|
33
Denali Therapeutics
DNLI
$2.93B
| $69M | 0.42% |
+4,410,457
| New | +$79.3M |
2017 Q4
0 quarters
|
|
34
Tuniu
TOUR
$53.8M
| $62.9M | 0.39% |
819,444
| – | – |
2015 Q4
8 quarters
|
|
35
Illumina
ILMN
$40.5B
| $60.6M | 0.37% |
285,024
| – | – |
2015 Q4
8 quarters
|
|
36
Coherus Oncology
CHRS
$162M
| $57.7M | 0.35% |
6,556,116
| – | – |
2017 Q3
1 quarter
|
|
|
MON
37
DELISTED
Monsanto Co
MON
| $50.1M | 0.31% |
429,184
| – | – |
2017 Q2
2 quarters
|
|
38
KKR Real Estate Finance Trust
KREF
$350M
| $48.8M | 0.3% |
2,439,024
| – | – |
2017 Q2
2 quarters
|
|
|
JUNO
39
DELISTED
Juno Therapeutics, Inc.
JUNO
| $41.9M | 0.26% |
915,750
| – | – |
2014 Q4
12 quarters
|
|
40
Biogen
BIIB
$34.8B
| $37.8M | 0.23% |
118,644
| – | – |
2017 Q2
2 quarters
|
|
41
Vertex Pharmaceuticals
VRTX
$129B
| $36.7M | 0.23% |
244,582
| – | – |
2017 Q2
2 quarters
|
|
42
Amgen
AMGN
$235B
| $32.8M | 0.2% |
188,527
| – | – |
2017 Q2
2 quarters
|
|
43
ICICI Bank
IBN
$106B
| $27.3M | 0.17% |
2,808,987
| – | – |
2016 Q2
6 quarters
|
|
|
CELG
44
DELISTED
Celgene Corp
CELG
| $26.7M | 0.16% |
255,406
| – | – |
2017 Q2
2 quarters
|
|
|
EMWP
45
DELISTED
Eros Media World PLC
EMWP
| $26.6M | 0.16% |
137,766
| – | – |
2014 Q3
13 quarters
|
|
46
Incyte
INCY
$23B
| $23.9M | 0.15% |
252,160
| – | – |
2017 Q2
2 quarters
|
|
|
47
State Street SPDR S&P Regional Banking ETF
KRE
$3.31B
| $20.2M | 0.12% |
343,800
-171,900
| -33% | -$9.88M |
2017 Q2
2 quarters
|
|
|
48
JPMorgan Chase
JPM
$891B
| $18.8M | 0.12% |
176,225
-88,112
| -33% | -$8.92M |
2017 Q2
2 quarters
|
|
49
AC Immune
ACIU
$244M
| $17.1M | 0.11% |
1,337,500
| – | – |
2016 Q3
5 quarters
|
|
|
NETS
50
DELISTED
Netshoes (Cayman) Limited
NETS
| $16.4M | 0.1% |
2,071,127
| – | – |
2017 Q2
2 quarters
|
|
Similar funds
Temasek Holdings's Q4 2017 Portfolio in Review
As of Q4 2017, Temasek Holdings held 67 positions worth $16.3B, down 5.3% from $17.2B the previous quarter. Its ten largest holdings account for 71% of the portfolio.
Temasek Holdings withdrew a net $922M in Q4 2017, closing 4 positions and reducing 6 holdings. Its most notable exit was Level 3 Communications Inc, an estimated $3.47B position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 44% of assets, up from 42% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Temasek Holdings opened a new position in Lumen Technologies, Inc. Common Stock worth $1.55B.
- Temasek Holdings's largest Q4 2017 buy was Lumen Technologies, Inc. Common Stock: 92,904,239 shares worth $1.55B.
- Temasek Holdings added most to BeOne Medicines Ltd in Q4 2017, an estimated $82.4M increase.
- Temasek Holdings's biggest Q4 2017 reduction was State Street SPDR S&P Regional Banking ETF, cutting an estimated $9.88M.
- Temasek Holdings fully exited Level 3 Communications Inc in Q4 2017, selling an estimated $3.47B.
- Temasek Holdings's ten largest holdings make up 71% of its $16.3B portfolio in Q4 2017.
- Temasek Holdings opened 6 new positions and closed 4 in Q4 2017.
- Temasek Holdings's portfolio value fell 5.3% quarter-over-quarter to $16.3B.
Based on Temasek Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.